Inflammation in Vascular Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGöteborg University
About this trial
Increasing evidence suggests that systemic low-grade inflammation may be a driving force of cardiometabolic complications, such as vascular dysfunction, atherosclerosis and ischemic heart disease. Thus, we will investigate the role of inflammation in cardiovascular disease.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patient is planned to undergo vascular surgery.
Signed informed consent has been obtained from the patient.
Disqualifiers
Patient has difficulty to understand information.
Patients under 18 years of age.
Patients participating in any drug-related study.
Trial population
Consecutive patients planned for vascular reconstruction surgery at our center.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
170 Participants
are grouped into 2 trial groupsGroup A: Control patients
Group B: Study patients
Trial outcomes
Primary outcomes
1
Inflammatory status
The inflammatory status will be studied in patients with atherosclerotic disease.
Time frame
2019-2024Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov